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The PI3K-AKT-FoxO pathway is integral to lifespan
regulation in lower organisms and essential for the
stability of long-lived cells in mammals. Here, we
report the impact of combined FoxO1, 3, and 4 defi-
ciencies on mammalian brain physiology with a
particular emphasis on the study of the neural stem/
progenitor cell (NSC) pool. We show that the FoxO
family plays a prominent role in NSC proliferation
and renewal. FoxO-deficient mice show initial
increased brain size and proliferation of neural pro-
genitor cells during early postnatal life, followed by
precocious significant decline in the NSC pool and
accompanying neurogenesis in adult brains. Mecha-
nistically, integrated transcriptomic, promoter, and
functional analyses of FoxO-deficient NSC cultures
identified direct gene targets with known links to
the regulation of human brain size and the control
of cellular proliferation, differentiation, and oxidative
defense. Thus, the FoxO family coordinately regu-
lates diverse genes and pathways to govern key
aspects of NSC homeostasis in the mammalian
brain.
INTRODUCTION
The PI3K-AKT-FoxO signaling pathway plays a central role in
diverse physiological processes relevant to aging and cancer.
This signaling axis translates extracellular cues into intracellular
gene expression changes to maintain cellular homeostasis. In
line with genetic studies in C. elegans and D. melanogaster
revealing an epistatic relationship across PI3K-AKT-FoxO, the
mammalian FoxO family of transcription factors (FoxO1, 3, and
4, hereafter referred collectively as FoxOs) also act as key down-
stream effectors of PI3K-AKT pathway and function to con-
trol many genes governing various cellular processes such as
proliferation, survival, metabolism, differentiation, and oxidative540 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Indefense (reviewed in Greer and Brunet, 2005). Recent studies
from our group have underscored that the mammalian FoxOs
function redundantly to promote the stability of long-lived cells
such as thymocytes and endothelial cells and to maintain hema-
topoietic stem cell (HSC) reserves that produce countless blood
cells over a lifetime. To control these processes across these
various systems, the FoxOs have been shown to regulate distinct
sets of gene targets depending on cell type, tissue context, and
developmental stage (Paik et al., 2007; Tothova et al., 2007).
The mammalian brain is a dynamic organ that maintains the
capacity to generate new neurons as a function of advancing
age and after brain injury. This regenerative capacity derives
from resident neural stem cells (NSCs) that contribute directly
to neurogenesis throughout development and adulthood. Pro-
cesses including the proliferation, differentiation, and fate deter-
mination of NSCs and progenitor cells, and the survival, matura-
tion, and integration of newborn neurons into existing neural
circuits have been shown to be necessary steps in adult neuro-
genesis. NSCs reside within the ventricular zone of the embry-
onic neural tube and, in adult brain, primarily in the subventricular
zone (SVZ) of the lateral ventricles and the subgranular zone
(SGZ) of the hippocampal dentate gyrus (DG). In adult mice, rela-
tively quiescent NSCs give rise to transit-amplifying progenitor
cells that rapidly divide and contribute to neuroblasts (Morshead
et al., 1994; reviewed in Zhao et al., 2008). Newly generated neu-
roblasts in the SVZ migrate to become granule and periglomer-
ular neurons in the olfactory bulb, and neurons born in the SGZ
migrate into the granule cell layer of the DG and become dentate
granule cells, contributing to the maintenance and reorganiza-
tion of the existing circuitry and affecting memory and behavior
(Imayoshi et al., 2008; reviewed in Zhao et al., 2008).
Recent studies have identified a number of pathways,
including the PI3K-AKT, PTEN, and TSC, governing embryonic
and tissue stem cell self-renewal, maintenance, and regenera-
tive responses (Gan et al., 2008; Groszer et al., 2001, 2006;
Paling et al., 2004; Yilmaz et al., 2006). Extracellular cues present
within the stem cell niche includeWnt, Hedgehog, bonemorpho-
genetic protein (BMP), fibroblast growth factor (FGF), epidermal
growth factor (EGF), and the transforming growth factor (TGFb),
all of which have been shown to affect self-renewal capacity bothc.
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et al., 2003; Palma et al., 2005; Reya et al., 2003). Furthermore,
several studies have underscored the importance of finely tuned
regulation of cell cycle/quiescence, apoptosis, and intracellular
redox status in the maintenance and fate determination within
tissue stem cell compartment (Cheng et al., 2000a, 2000b;
Doetsch et al., 2002b; Ito et al., 2004, 2006; Kippin et al., 2005;
Kozar et al., 2004; Malumbres et al., 2004; Yuan et al., 2004).
The molecular mechanisms by which the PI3K-AKT pathway
(and the FoxO family in particular) regulate NSC self-renewal,
proliferation, and differentiation in the developing ormature brain
are areas of active investigation.
On the basis of the fact that FoxOs had been reported to influ-
enceeachof theseprocesses inother systems (reviewed inGreer
and Brunet, 2005), and the importance of the FoxOs in the main-
tenance of HSC reserves (Miyamoto et al., 2007; Tothova et al.,
2007), and finally the highly cell type-specific nature of the
FoxO action (Paik et al., 2007), we sought to gain an in-depth
understanding of the specific functions of the FoxOs in the
mammalian central nervous system (CNS) with an emphasis on
the growth and renewal potential of neural stem and progenitor
cells (hereafter referred to collectively as ‘‘NSC’’). Here, an inte-
grated computational, molecular, cellular, and organismal anal-
ysis has identified and validated FoxO direct targets and their
linked pathways and biological processes that serve to regulate
various aspects of NSC biology including proliferation, survival,
renewal, and oxidative defense. This multilevel analysis estab-
lishes FoxOs as key molecules in processes central to NSC
homeostasis and defines the genes through which the FoxOs
execute their biological actions in this critical stem cell system.
RESULTS
FoxOs Constrain Proliferation and Sustain Renewal
of NSCs
Immunohistochemical analysis of wild-type adult mouse brain
shows that FoxO1 and 3 are broadly expressed in multiple cell
types including neurons (NeuN+), astrocytes (GFAP+), and oligo-
dendrocytes (Olig2+), in different locations as reported previ-
ously (Figures S1A and S1M–S1Q available online; Hoekman
et al., 2006). In particular, we documented high levels of FoxO1
and 3 expression in the multipotent progenitors (Sox2+) of the
SVZ in the forebrain and the SGZ in the hippocampus (Figures
S1C, S1E, S1I, S1M, and S1N). In the embryonic brain (E15.5),
FoxO1 and 3 also had broad and partially overlapping patterns
of expression particularly within the NSC-rich ventricular zone
(VZ). Within the VZ, FoxO1 expression is somewhat restricted
with the highest level of expression noted in Nestin-positive
radial glial progenitors of the dorso-medial wall of the VZ; in
contrast, FoxO3 is expressed more broadly throughout all
regions of the VZ examined (Figures S1J–S1L). As further
evidence for their potential functional relevance in the NSC, we
also detected high level expression of FoxO mRNA and proteins
in NSC-containing neurospheres cultured from embryonic and
postnatal brains (Figure S2). The prominent expression of
FoxO1 and 3 in NSC-rich regions of the developing and adult
brain, and FoxO1, 3, and 4 expression in cultured NSC-contain-
ing neurospheres from embryonic and adult brain prompted
further study of the FoxO family in these cells.CeTo circumvent embryonic lethality associated with impaired
vascular development because of broad FoxO1 deficiency
(Hosaka et al., 2004), we utilized conditional knockout alleles of
FoxO1, 3, and 4 (FoxO1/3/4L/L) to achieve somatic inactivation
of FoxO in the mouse brain. Here, we selected a particular
hGFAP-Cre transgenic line that has been well documented in
multiple published studies to be highly active in neural stem/
progenitor cells (Figures S1G and S1H; Zheng et al., 2008;
Zhuo et al., 2001; Lim et al., 2009) although it is also active in
developing and mature astrocytes. Indeed, nearly complete
deletion of FoxOs was observed in NSC-rich regions of adult
brain, including SVZ, in hGFAP-Cre: FoxO1/3/4L/L mice (Figures
S1B, S1D, S1F, and S1I).
FoxO1/3L/L allelic combinations with hGFAP-Cre showed
significantly increased overall brain size (i.e., thickness of
cortices and corpus callosum) and weight relative to hGFAP-
Cre-negative controls that was evident at 12 weeks of age (Fig-
ure 1A; Figures S3B and S3C). The low expression of FoxO4 in
these regions targeted by this particular hGFAP-Cre allele raised
the possibility that the increased brain size of hGFAP-Cre:
FoxO1/3/4L/L mice was predominantly due to FoxO1 and
FoxO3 deficiencies. Indeed, hGFAP-Cre:FoxO4L/L mice, alone
or in the triple knockout, exhibited a minimal effect on brain
size consistent with its low expression (Figure S3B). Consistent
with prominent FoxO1 and 3 coexpression patterns in vivo, com-
bined FoxO1 and 3 deficiencies (hGFAP-Cre: FoxO1/3/4L/L) had
a more pronounced effect on brain size than individual FoxO1 or
FoxO3 deficiency in the context of FoxO4 deficiency (hGFAP-
Cre: FoxO3/4L/L or :FoxO1/4L/L). Notably across all of the geno-
types, FoxO3 exerts the greatest phenotypic impact on brain
size as observed in both conditional and germline knockout
mice (Figure S3B; data not shown).
Histological inspection showed no apparent developmental
abnormalities or alterations in brain cytoarchitecture prior to
early adulthood (3 weeks of age) in any of the genotype combi-
nations (Figure S3A). At 10 days postnatally, the number of
both neurons and glia increased in cerebral cortex of FoxO-null
brain (NeuN+, 4486 versus 5024; S100+, 301 versus 402, p <
0.1) where almost all the cells underwent Cre-mediated recom-
bination as measured by reporter activity (Figure 1B). At approx-
imately 15 weeks of age, mild ventricular enlargement became
obvious in all three FoxO-deficient brains (Figures S4A and
S4B). The above coexpression profiles, coupled with high func-
tional redundancy among FoxO family members in the brain (this
study) and other tissues (Paik et al., 2007), prompted us to focus
our detailed phenotypic analyses on the triply null FoxO brains
(GFAP-Cre: FoxO1/3/4L/L hereafter referred to as ‘‘null’’ and
FoxO1/3/4L/L as ‘‘WT’’) for detailed CNS and NSC analyses.
To understand the basis for increased brain size, we examined
cell proliferation and size as a function of FoxO status in the
young brain (P8). FoxO deletion was nearly complete in Sox2-,
NeuN-, GFAP-, or Olig2-positive cell types in the FoxO-null brain
with the exception of a few anatomical regions (Figures S1I and
S1O–S1Q). A prominent increase in cell cycle re-entry (i.e.,
Ki67/BrdU/Sox2 triple-positive cells) among BrdU-labeled
population was evident in the NSC-rich regions of the SVZ in
FoxO-null brain (Figure 1C; 18.85% versus 10.82%, p < 0.01).
In contrast, detailed morphometric analyses showed no change
in the soma size of neurons or astrocytes in FoxO-null brainsll Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc. 541
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trophic astrocytes only in older FoxO-null animals (>32week) and
in vitro differentiated culture from late-passage FoxO-null NSCs
(Figures S5D and S5E). Together, these observations suggest
that FoxOs function to constrain the cycling of NSCs and/or
progenitor cells, but not their size, an observation in line with
Drosophila FoxO control of cell proliferation but not cell size
(Puig et al., 2003).
Given that the hGFAP-Cre transgene directs FoxO deletion in
NSCs as well as other CNS lineages (Figures S1O–S1Q; Zhuo
et al., 2001), we sought to further define the specific impact of
FoxO deficiency on NSC proliferation and renewal by using
well-established cell culture-based approaches. Ki67 expres-
sion (Figure 1D) and population doubling (Figure 2A) in NSC
cultures revealed that early-passage (P2) FoxO-null NSC cul-
tures had increased proliferation. Thus, FoxOs constrain the
proliferative activity of NSCs and/or progenitor cells in the young
adult brain and in early-passage cell cultures.
FoxO-Deficient Brains Exhibit Precocious NSC
Depletion
Although increased proliferation of FoxO-null NSC cultures was
observed initially, continued passage in culture showed ex-
haustion of neurosphere formation potential with accompanying
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Figure 1. Increased Brain Size and Cycling of NSCs in FoxO-Null Mice and Their Derived Culture
(A) Representative photograph of brains from 20-week-old FoxO WT (left) and null (right) mice.
(B) The number of glia and neurons was estimated by counting S100 or NeuN-positive cells in the cerebral cortex of 10-day-old FoxOWT (black squares) and null
(gray squares) pups. There are more S100 or NeuN-positive cells in FoxO-null brain compared with the control (*p < 0.1). ** indicates the region where S100+ and
NeuN+ cells were scored. hGFAP-cre mice were crossed with ROSA26R mice, where Cre-mediated recombination drives the constitutive expression of the
b-galactosidase. X-gal-staining-positive cells are shown in blue.
(C) Increase in cell cycle re-entry of FoxO-null SVZ cells. Young mice (P8) were single-pulse labeled with BrdU 24 hr prior to the sacrifice and brain sections were
stained for BrdU (red), Ki67 (green), and Sox2 (cyan). The fraction of Sox2-positive cells re-entered cell cycle (open arrow, BrdU+/Ki67+/Sox2+ triple positive)
increased in FoxO-null SVZ and that of no longer dividing (filled arrow, BrdU+/Ki67/Sox2+) is higher in WT SVZ. Percent mean ± SD of Ki67+ cells from
BrdU+/Sox2+ cells from 10 WT and 6 FoxO-null mice is shown (*p < 0.001 by two-tail t test). Scale bar represents 40 mm.
(D) Ki67-positive NSCs of FoxO WT and null cultures (n = 5, P2). Scale bar represents 20 mm.542 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc.
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Figure 2. Suppression of ROS Does Not Inhibit Hyperproliferation of FoxO-Null NSCs
(A) Proliferation of FoxOWT (blue line) and null (red line) NSCs (Rosa26-CreERT2+ and :FoxO1/3/4L/L, respectively) over the eight passages after 4OHT treatment
is plotted. y axis indicates log2 (cells counted after 5 days in culture/cells seeded). Result is representative of three independent cultures (*p = 0.0047; **p = 0.015).
(B) NAC treatment does not attenuate proliferation of FoxO-null NSCs. P2 NSCs were treated with up to 5 mM NAC for 24 hr and fraction of BrdU+ cells was
plotted. Scale bar represents 30 mm.
(C) NAC treatment does not inhibit increased cycling of Sox2+ cells in 8-day-old FoxO-null brain. 3-day-old FoxO-null mice were treated with NAC for 5 days
before sacrificed. Percent mean ± SD of Ki67+ cells from BrdU+/Sox2+ cells from NAC (n = 6) or water (n = 6) -treated FoxO-null mice is shown (p = 0.08 by
two-tail t test).
(D) Increased apoptosis in late-passage (P8) FoxO-null NSCs was reversed by 1 mM NAC treatment. No apparent changes in apoptosis were observed in early
passage (P2). Cleaved caspase3-staining-positive cells were scored and normalized by total number of DAPI-positive cells. Fractions of apoptotic cells are
plotted. *p = 0.017, **p = 0.021.decreased proliferation and marginally increased apoptosis
(Figures 2A and 2D; note the use of single-cell clonogenic assays
in Figure 3D, BrdU). This progressive renewal defect in cell
culture prompted closer examination of NSC reserves in vivo.
Staining brain sections with antibodies to Sox2, a marker for
NSCs, revealed that 15-week-old FoxO-null brain shows a signif-
icant 25% decline in Sox2-positive cells in the SVZ (Figure 3A;
gray bars, 1 versus 0.757, p = 0.004). In addition to the decrease
in Sox2-positive SVZ cells to levels well below FoxO WT brains,
there was an accompanying decline in doublecortin (DCX,
Figure 3B; gray bars, 1 versus 0.283, p = 0.0039) and Ki67
(Figure 3B; gray bars, 1 versus 0.717, p = 0.026) -positive cells
and a decline in the number of newborn neurons in the olfactoryCbulb to numbers below those in FoxO WT brains (1.76% versus
0.92%, p = 0.018; Figure S4C). Accompanying this decline in
NSC and neurogenic populations, the FoxO-null brain shows
consistent and progressive ventricular dilation and thinning of
the lateral ventricular wall and SVZ (Figures S4A and S4B;
100% versus 751.1%, p = 0.011). These pathological changes
were most evident in more aged brains, while absent in the
developing brain, suggesting that the loss of FoxO function in
the embryonic and adult brain together impacts most promi-
nently processes controlling the size and function of NSC pool
in postnatal mouse brain (Figures 3A and 3B; black bars).
The in vivo marker patterns suggesting a decline in NSC/
progenitor cell populations prompted us to perform a seriesell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc. 543
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measure the self-renewal capacity of cells derived from the fore-
brain of adult FoxO-null mice. The percentage of cultured cells
from adult FoxO-null mice (18- to 22-week-old) capable of form-
ing secondary multipotent neurospheres was lower than cells
derived from WT littermate controls (Figure 3C; 3.6% versus
1.3%). Specifically, FoxO-null cultures exhibited significant
reduction in proliferation by BrdU incorporation (Figure 3C; 0.2
versus 0.07, p = 0.03) and in average diameter of neurospheres
(Figure 3C; Figure S6A; 90.3 mm versus 61.4 mm, p = 0.0043).
Together, these findings suggest that FoxOs regulate the prolif-
erative and self-renewal potential of NSCs and that the loss of
FoxO function results in the progressive decline of NSC number.
It is important to emphasize that our experimental strategy
deletes FoxO in NSCs and other CNS lineages, thus potentially
affecting NSC biology directly and/or indirectly via alterations
in the surrounding microenvironment. Thus, we sought to assess
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Figure 3. FoxO-Deficient Brain Exhibits
Decrease in NSC Reserve and Neurogene-
sis
(A) Decreased Sox2-positive NSCs in 32-week-old
FoxO-null (right) brain. Scale bar represents
50 mm.
(B) Decline in neural progenitor proliferation and
neurogenesis measured by Ki67 and DCX expres-
sion in SVZ of lateral wall from 32-week-old FoxO-
null mice (right). 2003microscopic field of compa-
rable region from WT littermate control mouse is
shown (left). Insets are higher magnification view
of boxed regions. Scale bar represents 50 mm.
(A and B) Graphs at right: Sox2 (A), DCX (B), Ki67
(B) expression levels in young (8-week-old, black
squares) and relatively old (15- to 32-week-old,
gray squares) mice SVZ were measured by laser
scanning and plotted (4 pairs; *p = 0.004, **p =
0.0039, zp = 0.026, by two-tail paired t test).
(C and D) Decreased self-renewal capacity of
NSCs derived from 18- to 22-week-old FoxO-null
mice (C) and acutely deleted for FoxOs in vitro
(D). For conditional deletion, NSCs were isolated
from SVZ of 4-week-old Rosa26-CreERT2+ (null)
or (WT) FoxO1/3/4L/L mice and treated with
400 nM 4OHT prior to the assay. Results are repre-
sentative of three independent experiments with
two primary cultures. Both average diameters for
all the neurospheres and for multipotential ones
are shown as mean ± SD. Proliferation index is
shown as fraction of BrdU incorporation from trip-
licate cultures in two independent experiments.
xp = 0.0043, #p < 0.0001, *p = 0.01, **p = 0.03,
yp = 0.06, zp = 0.096 by two-tail t test. Scale bars
represent 100 mm.
whether deletion of FoxO upon in vitro
isolation and culturing would produce
the same phenotypes observed in NSC
cultures where FoxOs were deleted
in vivo. To that end, by using single-cell
clonogenic assays, we tested the self-
renewal capacity of NSCs from SVZ of
young adult mice (4-week-old) that was
subjected to acute FoxO deletion in vitro with an inducible Cre
system. Consistent with in vivo findings, acute in vitro deletion
of all three FoxOs with the transiently 4OHT-activated Rosa26-
CreERT2 system resulted in a same decrease in self-renewal
capacity (Figure 3D; 3.9% versus 1.9%, p = 0.096) along with
decreased average diameter of neurospheres (Figure 3D;
Figure S6B; 157.8 mm versus 98.6 mm, p < 0.0001) and prolifer-
ation as per BrdU incorporation (Figure 3D; 0.38 versus 0.16,
p = 0.010). Furthermore, an accompanying article shows that
deletion of FoxO3 alone in the brain via an independent Cre-de-
letor transgenic line, Nestin-Cre, which allows deletion in NSCs
(as well as other cell types), also produces similar decline in
NSC number both in vivo and in vitro (Renault et al., 2009, this
issue). The concordant phenotypes in vitro and in vivo, as well
as across multiple different experimental systems support the
view that precocious depletion of NSCs in FoxO-deficient brain
is, at least in part, a cell-autonomous phenomenon. Thus, we544 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc.
Cell Stem Cell
FoxOs Regulate Neural Stem Cell Homeostasispropose that the FoxOs function to support NSC homeostasis
in vivo, perhaps by preventing the rapid amplification of progen-
itors and the consequent exhaustion of the relatively quiescent
NSCs.
FoxO-Deficient NSCs Have Increased ROS
and Decreased Self-Renewal Potential
We have previously reported that loss of all three FoxOs in HSCs
results in decreased expression of ROS-detoxifying enzymes,
b-catalase, and manganese superoxide dismutase (MnSOD),
and that increased intracellular ROS levels in FoxO-null HSCs
are causally linked to enhanced G0 exit and increased apop-
tosis, resulting in progressive depletion of HSC reserves
(Tothova et al., 2007). To determine whether altered regulation
of genes involved in oxidative defense contribute to these similar
defects in NSCs, we performed the DCF-DA ROS measurement
assay, which showed an increase in intracellular ROS levels in
FoxO-null NSCs relative to WT control cultures (Figure 4A;
mean intensity level of 2904 versus 533). However, contrary to
the HSC findings of altered b-catalase and MnSOD expression,
the FoxO NSC transcriptome instead shows prominent dysregu-
lation of a distinct set of ROS detoxifying enzymes including
peroxiredoxin, glutathione peroxidase1, and sestrin3 (SESN3)
(Table S3). To examine whether ROS accumulation in NSC
also causally contributes to the biphasic phenotypes of hyper-
proliferation and/or long-term exhaustion, we reduced ROS
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Figure 4. Regulation of NSC Self-Renewal by FoxO through Controlling Intracellular ROS Level
(A–D) Accumulation of intracellular ROS in FoxO-null NSCs (P7) is measured by DCF-DA staining and flow cytometry. Numbers indicate mean intensity level (A)
and percent of total event above the threshold (C). Both NAC treatment (1 mM) and enforced expression of SESN3 normalized and suppressed ROS level (A, C)
and partially rescued self renewal in FoxO-null NSCs (B, D). Expression of SESN3-v5 in NSCs is shown below by immunobloting of v5 epitope (C).
(B and D) Representative images of cultured neurospheres from two independent experiments are shown. Both average diameters for all the neurospheres and
for multipotential ones are shown as mean ± SD. Proliferation index is shown as fraction of BrdU incorporation from triplicate cultures in two independent exper-
iments. *p < 0.01, yp < 0.05 by ANOVA with Bonferroni’s post test. Scale bars represent 100 mm.Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc. 545
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(NAC) or by enforcing the expression of SESN3, a cysteine sul-
finic acid reductase that reduces peroxiredoxins. Normalized
(by NAC) or reduced (by enforced SESN3) intracellular ROS
levels (Figures 4A and 4C) enhanced the self-renewal capacity
of FoxO-null NSC cultures as measured by neurosphere forma-
tion assay (Figures 4B and 4D; 0.9% versus 2.6% and 1.4%
versus 3.0%, respectively, p < 0.05). In particular, the late
passage (P7) of NAC-treated or SESN3-transduced FoxO-null
NSCs showed improved proliferation as measured by BrdU
incorporation (Figures 4B and 4D; 0.09 versus 0.21, p < 0.01),
decreased apoptosis (Figure 2D), and increased overall neuro-
sphere diameter (Figures S6C and S6D).
In contrast, in the early-passage FoxO-null NSCs, NAC treat-
ment (up to 5 mM) had no effect on the transient hyperprolifera-
tion phenotype nor did it affect the proliferation of FoxO WT
NSCs (Figure 2B; con versus NAC, 0.295 versus 0.294, p =
0.966, P2). Furthermore, in vivo administration of NAC did not
suppress increased cycling of Sox2+ cells in postnatal FoxO-
null brains (Figure 2C; NAC versus PBS, 21.3% versus 18.9%,
p > 0.05), supporting the view that increased ROS plays no
discernable causal role in increased proliferation of FoxO-null
NSCs in the young postnatal brain. Together, these studies
suggest that, while FoxO-directed regulation of intracellular
ROS level plays an important role in NSC self-renewal capacity,
it plays no discernable role in controlling the proliferation activity
of the NSCs.
Identification of FoxO Transcriptional Targets
Regulating NSC Biology
The lack of complete rescue of the self-renewal defects, even
with normalization of ROS by NAC treatment, pointed to addi-
tional FoxO-regulated pathways governing NSC biology. To
identify functionally relevant FoxO direct gene targets and their
linked physiological actions, we conducted unbiased transcrip-
tomic profiles in WT and FoxO-null NSCs and in silico promoter
analysis followed by confirmatory biochemical and biological
validation studies.
Transcriptomic analysis of multiple independent FoxOWT and
null early-passage neurosphere cultures revealed differential
regulation of 3425 genes by FoxOs as determined by two inde-
pendent statistical methods (Table S1). Among these are known
effectors of FoxO and their family members (e.g., Cyclin D1,
Inhibitor of DNA binding 1 and 2, and Polo-like kinase 2) (Alvarez
et al., 2001; Birkenkamp et al., 2007; Schmidt et al., 2002) as well
as many potential novel FoxO targets that relate well to our bio-
logical observations including cell cycle (e.g., G two and S phase
expressed1, Cdk inhibitor 1C, Sal like2) and glial differentiation
(e.g., Hes5, Sox10, Myelin basic protein, Plp1, Cystatin C) and
that functionally interact with FoxOs (e.g., FoxG1, Sirt2) (Seoane
et al., 2004; Wang et al., 2007). Notably, the NSC FoxO trans-
criptome demonstrates minimal overlap with other cell types
including HSCs—a finding in line with previous observations
that the FoxOs regulate their targets in a highly cell type-specific
manner (i.e., the FoxO transcriptomes of HSC, thymocytes, or
endothelial cells show minimal overlap) (Paik et al., 2007;
Tothova et al., 2007). Nevertheless, despite these cell type-
specific gene target differences, knowledge-based pathway
analysis showed convergent regulation of well-known FoxO546 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Innetworks such as IGF-1/PI3K/PTEN, cell cycle, and metabolic
pathways (data not shown).
Next, we sought to identify direct FoxO targets in order to gain
further insights into FoxO’s role in NSC biology. To that end,
a systematic and validated in silico promoter analysis approach
(Paik et al., 2007) was used to identify evolutionarily conserved
FoxO consensus binding elements (BE) in the regulatory regions
of the top 186 genes (144 downregulated, 42 upregulated in
FoxO null) that show the most significant expression differentials
(SAM > 2; and see Experimental Procedures) (Table S2). To
search for FoxO BE, each gene region was surveyed from 10
kb up- or downstream of the transcription start or end site. By
this approach, 96 of the 186 genes were found to contain puta-
tive conserved FoxO BEs. 18 of the 96 genes from diverse gene
ontology categories were selected and their direct regulation by
FoxOs was tested on several levels including (1) differential
mRNA expression by RT-qPCR in FoxO null versus WT, (2)
adenoviral-transduced expression of active form of FoxO1 and
3 (CA-FoxO1/3) (Figure S8A), (3) documentation of physical
binding of FoxOs on predicted BE by chromatin immunoprecip-
itation (ChIP) (Figure S8B), and (4) confirmation of target gene
differential expression by RISH in FoxO WT and null embryonic
brains (data not shown). Of the 18 putative targets tested, these
integrated analyses and highly stringent criteria confirmed 8
bona fide novel FoxO direct targets (Aspm, Tmeff2, Sirt2, Kitl,
Tspan7, Sfrp1/2, and Sost). Several of these FoxO targets have
plausible, albeit unexplored, links to NSC biology prompting
further functional study.
FoxOs Directly Repress ASPM Expression
in the Regulation of NSC Proliferation
The FoxO NSC transcriptome and pathway analyses were
notable for alterations in proliferation and differentiation
networks, the imbalance of which may provide an explanation
for the enlarged brain phenotype and the abnormal cycling that
could ultimately lead to exhaustion of NSCs. For example, there
is increased expression of cyclins (CcnA2,B1,B2,C,D1,D3,E1,
G1, T2) and cyclin-dependent kinases (Cdk 2, 4, 7) and decrease
in specific cyclin-dependent kinase inhibitors (p57KIP2) that
correlate well with observed short-term hyperproliferation
phenotype in FoxO-null NSCs (Table S1). A notable cell cycle
gene that may relate to the FoxO-null brain size phenotype is
Aspm (abnormal spindle-like microcephaly-associated) gene.
In humans, ASPM is a determinant of human cerebral cortical
size, i.e., individuals with ASPM germline loss-of-function muta-
tions show primary microcephaly (Bond et al., 2002). ASPM
expression has been shown to be required for symmetric, prolif-
erative divisions of neural stem/progenitor cells of the mamma-
lian brain (Fish et al., 2006; Horvath et al., 2006).
Consistent with the relevance of the FoxO-ASPM link in NSC
biology, we observed (1) significantly increased Aspm mRNA
levels in FoxO-null NSCs by RT-qPCR (Figure 5A), (2) increased
ASPM protein and mRNA in NSC-rich regions of FoxO-null
embryonic brains (Figure 5B, RISH, not shown), and (3) increased
ASPM-positive cells in FoxO-null NSC cultures (Figure 5C).
Second, in silico methods (Paik et al., 2007) identified evolution-
arily conserved FoxOBEs in the Aspmpromoter whichwere con-
firmed to bind FoxO by ChIP assay in NSCs (Figure 5D). Third, on
the functional level, Aspm shRNA-mediated knockdown (twoc.
Cell Stem Cell
FoxOs Regulate Neural Stem Cell Homeostasisindependent hairpins) resulted in a profound decrease in prolifer-
ation of FoxO-null NSCs (Figures 5E–5G; 0.41 versus 0.06 and
0.11 for BrdU incorporation, p < 0.01). Notably, NSCs with
Aspm knockdown exhibited significant decrease in size of neu-
rospheres and self-renewal potential in single-cell clonogenic
assays (Figure 5G; Figure S6E; 95.4 mm versus 48.2 mm and
54.1 mm in average diameter, p < 0.01 and 1.6% versus 0 and
0.3% for self-renewal, p < 0.05), a phenotype associated with
increased cell cycle exit and differentiation (data not shown).
Thus, Aspm is a physiologically relevant target of FoxO in the
regulation of proliferation and the renewal of NSCs. We propose
that the derepression of Aspm in FoxO-null NSCs contributes to
the observed short-term hyperproliferative defects in this
progenitor compartment and the enlarged brain phenotype.
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Figure 5. FoxO-Dependent Expression of ASPM Regulates NSC Proliferation
(A and B) Differential expression of AspmmRNA in FoxOWT and null embryonic NSCsmeasured by RT-qPCR (A) and protein by IHC analysis (B) on FoxOWT and
null E15.5 embryonic brain. Scale bar represents 50 mm.
(C) Number of mitotic spindle-localized ASPM-positive NSCs in FoxOWT and null cultures. Representative images are shown below. Scale bar represents 10 mm.
(D) The Aspm promoter is occupied by both FoxO1 and FoxO3 in NSCs. On the schematic representation of the Aspm promoter, FoxO binding sites are depicted
relative to the +1 transcriptional start site. ChIP analysis of NSCs with FoxO1, FoxO3, IgG, or PolII antibodies. Primers were designed to encompass the FoxO
binding sites.
(E) Knockdown of Aspm by shRNAs in FoxO-null NSCs. Aspm mRNA level was measured by RT-qPCR after 48 hr of shAspm lentiviral transduction.
(F and G) Decreased proliferative potential in Aspm knockdown NSCs was measured by BrdU incorporation assay (F) and neurosphere formation (G). *p < 0.01,
#p < 0.05 by ANOVA with Bonferroni’s post test. NA, not analyzed, NT, nontargeting control shRNA-infected culture. Scale bars represent 100 mm.Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc. 547
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The FoxO transcriptome is also notable for regulatory factors of
the Wnt pathway, a pathway whose stringent control is required
for the long-term homeostasis of many tissue stem cells. In
particular, there was significant downregulation of soluble friz-
zled receptors (Sfrp) 1 and 2 as well as sclerostin (Sost) in
FoxO-null NSC transcriptome (Table S1). First, as above, the
link between FoxO status and these factors was confirmed by
their higher mRNA expression in FoxO WT relative to FoxO-null
NSCs (Figure 6A) and by the presence of conserved ChIP-
validated FoxO binding elements in their promoters (Figure 6B).
Second, enforced expression of constitutively active (CA)-
FoxO1 or 3 can induce expression of Sfrp1/2 and Sost in
FoxO-null NSCs (Figure S8A). Third, because these soluble
factors act as an antagonist for Wnt ligands, we utilized the
TOFlash reporter system to measure the activity of canonical
Wnt pathway in our system. Addition of Wnt3a, but not Wnt5a,
induced TCF/Lef/b-catenin-dependent transcriptional activity,
confirming the specificity of reporter activity responsive to
the canonical Wnt signaling. This response is reproducibly
enhanced in FoxO-null NSCs (Figure 6C). Conversely, enforced
expression of CA-FoxO1 or 3 suppressed reporter activity (i.e.,
dampened Wnt signaling) (Figure 6D). In agreement with the
reporter assays, the expression of the targets dependent on
Wnt signaling including Cyclin D2 and Myc were upregulated in
FoxO-null NSCs (Figure S7A). Fourth, RNAi-mediated knock-
down of sFRP1/2 and SOST was performed to examine the
role of these factors in FoxO-mediated repression of Wnt
signaling in NSCs. Combined knockdown of all three sFRP1/2
and SOST resulted in a 1.5-fold increase in Wnt3a-induced
reporter activity and this increase was completely reversed by
the addition of recombinant sFRP1/2 and SOST (Figure S7B;
Figure 6E). Knockdown of individual factors did not cause appre-
ciable differences in Wnt3a-induced reporter activity (data not
shown), suggesting that these novel FoxO targets act coopera-
tively as soluble inhibitors of the Wnt pathway to repress Wnt
signaling in NSCs.
Finally, we examined the biological impact of FoxO-repressed
Wnt signaling on NSC proliferation. Exogenous Wnt3a treatment
can induce a strong proliferative response in NSCs, and corre-
spondingly, both FoxO-null and sFRP1/2 and SOST knockdown
NSCs showed increased basal proliferation that was significantly
inhibited by the addition of sFRP1/2 and SOST (Figure 6F).
However, it is important to note that the Wnt3a-induced prolifer-
ative response is short lived and is followed by substantial
decline in number of cycling cells, resembling the growth kinetics
of FoxO-null NSC culture (Figure 6G). These observations further
reinforce the cross talk between FoxO and Wnt signaling path-
ways in NSCs and the importance of finely tuned Wnt pathway
activation in the long-term homeostasis of NSCs.
DISCUSSION
In this study, an integrated molecular, cellular, and organismal
analysis has established FoxOs as essential regulators of genes
governing processes central to NSC biology (Figure 7). Disrup-
tion of these FoxO-dependent homeostatic processes in the
mouse brain leads to initial deregulated NSC proliferation fol-
lowed by a decline in NSCpool and accompanying neurogenesis548 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inthat is evident only in adult mice. The abnormal proliferation
kinetics of NSCs in vitro and in vivo and the enlarged brains
in FoxO-deficient brains establishes a role for FoxOs in the
enforcement of NSC quiescence and control of NSC self-
renewal. Mechanistically, a combined transcriptomic, computa-
tional, and biochemical analyses have identified a diverse set of
direct functional targets and linked pathways through which
FoxO directly executes its complex actions on NSCs and brain
physiology.
Gradual depletion of NSCs in FoxO-null animals might be
explained by a cell-autonomous role of FoxOs in regulating adult
self-renewal potential. Alternatively, increased cell cycling during
the development and establishment of NSC pool in the FoxO-null
brain may lead to later decline in their number by intrinsic
mechanism to adjust the size of stem cell pool within the niche.
Despite the reinforcing parallel findings of our in vitro analyses
showing an impact of FoxO deletion on NSC biology, it is
possible that some of the NSC phenotypes derive in part from
the broad deletion of FoxOs in cellular compartments other
than the NSCs in the adult brain. However, it is worth noting
that neuron-specific deletion of FoxOs (Syn-Cre: FoxO1/3/4L/L)
is not accompanied by NSC abnormalities (data not shown).
Nevertheless, we acknowledge that specific deletion of FoxOs
only in mature astrocytes or only in adult NSCs will be needed
to distinguish whether FoxOs exert their actions on NSC homeo-
stasis via altered astrocyte support functions or by acting
in NSCs. Our validated collection of FoxO targets establishes
strong evidence that FoxO regulates ROS detoxification,
Wnt signaling, cell cycle, and differentiation processes, which
collectively serve to fine-tune the balance of growth, survival,
and differentiation needed to achieve the regulation of NSCs
throughout life (Figure 7).
The precocious decline in the NSC pool and neurogenesis in
FoxO-null mice at 6 months of age indicates that FoxOs are
important regulators of NSC function and renewal under physio-
logical conditions in the brain. Consistent with functional redun-
dancy among FoxOs in other tissues (Paik et al., 2007), the single
and double FoxO-null brains show overtly normal patterns
of neurogenesis through mid-adulthood (F.M. and R.A.D.,
unpublished observations). However, we also acknowledge
that it remains possible that single (particularly FoxO3) FoxO-
null mice may also experience more subtle decline in CNS func-
tion. Indeed, the accompanying study by Renault et al. (2009)
demonstrates that lack of FoxO3 alone in the brain is sufficient
to cause a defect in NSC number in vivo, a result suggesting
a dominant role of FoxO3 relative to other FoxO family member
in the brain.
That FoxO deficiency leads to transient increase in cycling
cells is not unanticipated based on previous studies with
other PI3K pathway components wherein loss of the negative
regulator PTEN was shown to result in sustained proliferative
potential of NSCs (Groszer et al., 2001, 2006). In contrast,
the FoxO-null NSC/progenitor proliferation is distinct from
that of PTEN-null NSCs in that it does not show sustained
increased proliferation.When viewed through themultiple mech-
anistic findings of our study, we speculate that increased
proliferation and ultimate precocious decline of NSCs and asso-
ciated neurogenesis results from the combined impact of loss of
fine-tuned cell cycle/quiescence control by dysregulation ofc.
Cell Stem Cell
FoxOs Regulate Neural Stem Cell HomeostasisA
B
D
E G
TSS
-1920 
TSS
-1419   
TSS
-291   
F
*
* *
0
4
8
12
Fo
xO
1 
Fo
xO
3 
Ig
G
P
ol
II0
4
8
12
Fo
xO
1 
Fo
xO
3 
Ig
G
P
ol
II
%
 o
f t
ot
al
 in
pu
t sFRP1 sFRP2
0
6
12
18
Fo
xO
1 
Fo
xO
3 
Ig
G
P
ol
II
SOST
cont
null KD
wnt3a
null+sFRP1/2+SOST KD+sFRP1/2+SOST
- +   - +   - +   - + 
0
0.25
0.5
0.75
1
Cont      null    KD    Wnt3a
Fr
ac
tio
n 
of
 K
i6
7+
 c
el
ls
  
sFRP1/2+SOST
*
*
*
%
 o
f t
ot
al
 in
pu
t 
0
1
2
3
4
1 2 3 4 5 6 7 8
Po
pu
la
tio
n 
do
ub
lin
g 
 
Passage #
#
*
**
**
0
0.0003
0.0006
0.0009
0
0.0005
0.001
0.0015
0
0.0008
0.0016
0.0024
WT    null 
m
R
N
A
 e
xp
re
ss
io
n sFRP1 sFRP2 SOST
cont CA1 LacZCA3
0
2
4
6
8
TOFlash
Fo
ld
 o
ve
r c
on
tro
l
- +     - + - +     - +Wnt3a
0
10
20
30
TOFlash
vehicle   Wnt3a   Wnt5a
A
rb
itr
ar
y 
nu
m
be
r
WT    null WT    null 
0
6
12
18
- +     - +     - +     - + Wnt3a
Fo
ld
 o
ve
r c
on
tro
l
TOFlash
sFRP1/2+SOST - - - - +     +     +    + 
* **
**
C
**
Figure 6. FoxOs Negatively Regulate Wnt Signaling in NSCs
(A) Expression of soluble antagonists of Wnt. Differential expression of Sfrp1/2 and Sost mRNA in FoxO WT and null embryonic NSCs measured by RT-qPCR.
(B) Promoters for Sfrp1/2 and Sost are occupied by both FoxO1 and FoxO3 in NSCs. On the schematic representation of the promoter FoxO binding sites are
depicted relative to the +1 transcriptional start site. ChIP analysis of NSCs with FoxO1, FoxO3, IgG, or PolII antibodies. Quantification of ChIP analysis on each
promoter was assessed by RT-qPCR analysis.
(C) Wnt3a-induced canonical Wnt signaling is measured by TOFlash reporter assay. Note enhanced signal in FoxO-null (gray squares) NSCs compared to WT
(black squares). *p = 0.08053.
(D) Attenuated Wnt3a-dependent canonical signaling by constitutively active FoxOs. CA1, CA3; FoxO1-ADA and FoxO3-AAA mutant, respectively. *p < 0.1.
(E) Enhanced canonical signaling in Sfrp1/2 and Sost knockdown NSCs (black squares) compared to WT (gray squares) is reversed by the addition of soluble
sFRP1/2 and SOST (500 ng/ml). *p = 0.068; **p < 0.005.
(F) Exogenously added sFRP1/2 and SOST (500 ng/ml) reversed increased proliferation of FoxO-null NSCs.Wnt3a, 50 ng/ml of recombinant wnt3a was added for
24 hr. KD, 72 hr after knockdown by siRNAs for Sfrp1/2 and Sost. Fractions of Ki67-positive nuclei are plotted.
(G) Decreased long-term proliferation potential of NSCs byWnt3a stimulation (100 ng/ml). y axis indicates log2 (cells counted after 5 days in culture/cells seeded).
Lines in red, FoxO null; blue, WT; yellow, Wnt3a-treated. *p = 0.0041; **p < 0.01; #p = 0.0169.Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc. 549
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FoxOs Regulate Neural Stem Cell Homeostasismolecules such as the p57KIP2 cell cycle inhibitor, ASPM, and
WNT dampeners, among others. Beyond cell cycle regulation,
it is possible that altered lineage commitment may also
contribute to a decline in neurogenesis as indicated by the fact
that the FoxO-null transcriptome shows changes of key develop-
mental regulators (J.-h.P. and R.A.D., unpublished), a finding in
line with previously reported role for FoxOs in cellular fate deter-
mination observed in myogenesis and hematopoiesis (Hu et al.,
2008; Kitamura et al., 2007; Tothova et al., 2007). Thus, the
FoxOs appear to regulate many cellular processes that require
fine regulation to maintain the right balance of proliferation,
survival, and cell fate commitment decisions in tissue stem cell
pools, while responding to the regenerative needs of tissues
throughout life (Figure 7).
Our analysis of the FoxO-null NSC transcriptome, along with
analogous studies in the HSCs, confirm that FoxOs have con-
served roles across different stem cell compartments via regula-
tion of distinct lineage-specific sets of genes governing prolifer-
ation and intracellular ROS levels. However, relative to FoxO
function in the HSCs (Tothova et al., 2007), this report estab-
lishes that its function in the NSCs shows a greater diversity of
activities and pathway engagement. For example, the finding
of Aspm as a direct target of FoxOs in NSCs is notable given
the hypothetical role of ASPM as one of the genetic determinants
underlying the positive selection in cerebral cortical size across
different species (Bond et al., 2002). Significantly, ASPM defi-
ciency was discovered to be the basis for a human genetic
disorder characterized by microcephaly, which presents with
reduced neurogenesis. Our findings that Aspm is one of the
major targets of FoxOs and its knockdown limits expansion of
the FoxO-null NSC cultures suggests that ASPM contributes to
increased FoxO-null brain size phenotype via its known activities
in the control of neural progenitor cell biology (Fish et al., 2006).
Our identification of Sfrp1/2 and Sost as direct targets of
FoxOs also supports the view that the FoxOs regulate NSC
cellular responses to the extracellular signals via a coordinated
regulation of specific target genes. Here, we establish that
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Figure 7. Model for FoxO-Dependent Regulation of
NSCs
FoxOs control NSC biology at multiple levels. FoxOs (A) nega-
tively regulate G0 exit of NSCs and keep their quiescence
within the niche, (B) support their long-term self-renewal
activity, (C) constrain proliferation of lineage-committed neural
progenitors, and (D) contribute to continued neurogenesis.
FoxOs engage the Wnt pathway on many levels
to ensure a tight regulation of NSCs. We observe
that enhanced Wnt pathway activity in FoxO-null
NSCs leads to an acute short-term increase in their
proliferation. Although the ensuing depletion of
long-term self-renewal potency may relate to
the dominance of other dysregulated pathways
(see below), hyperactivity of Wnt signaling could
paradoxically contribute to this decline as well.
This possibility derives from the mechanistic
analysis of the accelerated aging phenotype of
klotho-deficient mice, a mutant mouse manifesting
augmented Wnt signaling (Liu et al., 2007). As
exemplified in this study, loss of soluble antagonist for Wnt leads
to cellular senescence caused by continuous Wnt signaling
contributing to suppression of the number of stem/progenitor
cells. Furthermore, consistent with a possible role of elevated
Wnt signaling in stem cell maintenance, addition of Wnt has
been shown to convert myogenic progenitor culture into fibro-
genic lineage (Brack et al., 2007). Thus, whereas Wnt signaling
is clearly essential for tissue stem cell renewal, the loss of finely
tuned Wnt pathway activity in a narrow window in the FoxO-null
NSCs could contribute to the defective maintenance via the
collective impact of aberrant proliferation activity and presum-
ably altered cell fate.
In summary, this study shows that the mammalian FoxOs
have evolved to serve as prolongevity tumor suppressors
designed primarily to maintain the homeostasis and the integrity
of long-lived cells including tissue stem cell reserves. This con-
trasts with other tumor suppressors (e.g., p16Ink4a) that appear
to suppress cancer at the cost of tissue-resident stem cells
and therefore may contribute to decreased regenerative poten-
tial during the aging process (Krishnamurthy et al., 2006; Molof-
sky et al., 2006). The impact of FoxO activity on the CNS health
under aging and stress, especially how FoxOs regulate NSCs in
the aging brain, may prove useful for defining strategies to
modulate regenerative response in the setting of acute brain
injury or long-term degenerative conditions. Specifically, such
insights may inform the development of drugs targeting path-
ways that may impair or improve CNS health in aging, neurode-
generative diseases, and injury states including those associ-
ated with medical treatments such as cancer chemo/radiation
therapy.
EXPERIMENTAL PROCEDURES
Generation of Mice
All experimental and control animals were littermates or age matched. An
hGFAP-Cre+ male was mated with a FoxO1L/L; FoxO3L/L; FoxO4L/L (FoxO1/
3/4L/L) female, and the progeny were then crossed with FoxO1/3/4L/L mice.550 Cell Stem Cell 5, 540–553, November 6, 2009 ª2009 Elsevier Inc.
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genotypes. For the mapping of Cre activity, hGFAP-Cre+ mouse was bred
with ROSA26R reporter mouse (Soriano, 1999) and X-gal staining was per-
formed to locate cells expressed Cre. For in vitro deletion of FoxOs, embryonic
or adult NSCs were isolated from Rosa26-CreERT2+ (kindly provided by Anton
Berns, The Netherlands Cancer Institute, Amsterdam, The Netherlands);-
FoxO1/3/4L/L mice (Hameyer et al., 2007). These mice were generated with
above mating scheme. All the mice were cared and monitored according to
DFCI animal research facility guideline.
Neurosphere Formation
Primary neurospheres were dissociated and seeded at 2 cells/ml density in
multiwell plates. After 7–10 days, cultures were monitored for the formation
of neurospheres. Alternatively, single cells were sorted into individual well on
384-well plate on Dako MoFlo high-speed cell sorter and cultured for 3 weeks.
Neurospheres were transferred to culture wells coated with poly-L-ornithine
(15 mg/ml) and fibronectin (1 mg/ml) and differentiated in 1% FBS in neurobasal
media to measure their multipotentiality. Quantification of neurosphere
numbers and diameters were performed by bright-field microscopy coupled
with an in-house semiautomated segmentation algorithm generated with
MATLAB software (The Mathworks, Natick, MA).
Intracellular ROS Measurement
FoxOWT and null NSCs were incubated with NAC (1 mM) or H2O2 (100 mM) for
entire culture period or 30 min, respectively. DCF-DA (25 mM, Molecular
Probes) was added to cultures and incubated for an additional 30 min at
37C. Levels of fluorescent adduct wasmeasured by flow cytometry with exci-
tation at 488 nm.
Measuring NSC Apoptosis and Proliferation
For analysis of apoptosis, NSCs were fixed with 4% paraformaldehyde, per-
meabilized, and stained for cleaved caspase-3 (Calbiochem). For BrdU incor-
poration, BrdU-treated (6 mg/ml, 2 hr) cells were fixed and treated with 2N HCl
for 15 min and permeabilized with 0.2% Triton X-100 followed by primary
mouse anti-BrdU (1:200, Roche, Bu20a) incubation followed by secondary
antibody labeling as below.
In Vivo Administration of NAC
NAC (500 mg/kg, Sigma) and BSO (5 mmol/kg, Sigma) were dissolved in PBS
and injected subcutaneously for 5 days starting from P3. On day 4 (P7), mice
were intraperitonically injected with 1 mg of BrdU. 24 hr after BrdU injection,
mice were sacrificed and analyzed.
Reporter Assay for Cannonical Wnt Pathway
500 ng of reporter construct TOPFLASH (kindly provided by Randall Moon)
was transfected into 1 3 106 FoxO WT and null NSCs with Lipofectamine
2000. 50 ng of pTk-renilla control vector was cotransfected as an internal
control. 50 ng/ml of recombinant Wnt3a or Wnt5 (R&D systems) was added
to media and 48 hr after transaction cells were lysed and analyzed for lucif-
erase with the Dual Luciferase Reporter Assay system (Promega) according
to the manufacturer’s instructions.
Quantitation of Neurons and Glia
Brains sections from four littermates WT and FoxO-null mice (P10) were
stained for NeuN and S100. Positive cells with the cerebral cortex region dorsal
to the hippocampal formation were scored.
Laser Scanning Analysis for the Quantitation of IHC
Laser scanning cytometry quantification of DCX and Sox-2 was performed by
iCys Research Imaging Cytometer (Compucyte) as described early (Gorczyca
et al., 2001) with a few following modifications. Counts of DCX+ or Sox2+ (DAB
positive) were carried out within the subventricular zones that were predefined
by a certified pathologist with the H&E-stained brain architecture. The target
number for each sample was approximately 500 cells counted. The size of
ventricular area and thickness of corpus callosum and cortex was measured
by ImageJ software. The paired t test was used to compare the differences
between wild-type and FoxO-null brains.CeStatistical Analysis
All the data were analyzed by unpaired two-tail Student’s t test unless speci-
fied in the figure legend.
ACCESSION NUMBERS
Themicroarray data have been deposited in the GOE database with accession
number GSE18308.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, eight
figures, and three tables and can be found with this article online at http://
www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00509-8.
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